Detectability of fiducial markers in an MRI-only radiotherapy treatment workflow for prostate
In a conventional prostate cancer radiotherapy treatment workflow, computed tomography (CT) and magnetic resonance imaging (MRI) are used for radiotherapy treatment planning and target delineation. MRI is necessary in the process due to better soft tissue contrast compared to CT-images. Using two different imaging modalities in radiotherapy treatment planning requires image registration, which cou
